Pulse Biosciences, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Pulse Biosciences, Inc. (PLSE) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-02-19
- Pulse Biosciences, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-09-30 was $8.00K.
- Pulse Biosciences, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-06-30 was $1.07M.
- Pulse Biosciences, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-03-31 was $107.00K.
- Pulse Biosciences, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Pulse Biosciences, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $830.00K.
- Pulse Biosciences, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $0.00.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-19 | |||
| 2024-12-31 | $830.00K 10-K · filed 2026-02-19 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 | |||
| 2019-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.08M derived: sum of 2 quarters · filed 2019-11-07 | $1.19M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.18M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $107.00K 10-Q · filed 2019-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |